Johnson & Johnson has laid out plans to raise U.S. investments by 25% to more than $55 billion over the next four years, as a threat of drug import
The U.S.
NASA is eliminating its chief scientist role and closing down an office that studies policy matters on space and technology, in a round
A U.S. federal judge has
Eli Lilly plans to spend at least $27 billion to build four new manufacturing plants in the U.S., the drugmaker said at a Washington press
Johnson & Johnson sued Samsung Bioepis for allegedly breaching a contract agreement over its launch of a biosimilar to Stelara, J&J's blockbuster
Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded the range of doses sold online to try
The U.S.
The U.S. regulator charged with monitoring large national banks told staff on Friday it was firing 76 probationary employees, making it
The U.S.
Elon Musk's DOGE team has slashed hundreds of jobs paid for by fees from banks, medical device companies and other forms of funding
Moderna said on Friday that the U.S.
Robert F.
Eli Lilly on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing investor agitation about
President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from his new tariffs on Chinese imports,
Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales of popular weight-loss drug Zepbound after
Johnson & Johnson, fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular, reported fourth-quarter revenues and profit above Wall
The United States will leave the World Health Organization, President Donald Trump said on Monday, saying the
Johnson & Johnson on Tuesday reported quarterly results just above Wall Street expectations, helped by strong sales of its blockbuster psoriasis drug
All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiations for the U.S.
More than 7 million Americans had rolled up their sleeves for the updated COVID-19 vaccines as of Wednesday, according to the U.S.
Johnson & Johnson on Tuesday said it has embarked on a two-year restructuring program for its orthopedics business after third-quarter medical devices
Moderna on Thursday said it expected 2023 revenue of at least $6 billion, a decline reflecting weaker demand for COVID-19 vaccines this year, but that it would return
Backlash continues against Elon Musk’s role with DOGE as demonstrations at Tesla showrooms enter fifth week
OpenAI, Meta in talks with Reliance for AI partnerships, The Information reports
Patel plans major cutback to ATF by moving many as 1,000 agents to FBI
Russian authorities bring in trains to fight oil depot fire
Israel anti-government protests flare after dismissal of top security agency chief
Trump's Social Security chief backs down from 'shutting down' agency
McNeese's Will Wade signs a 6-year deal to become NC State coach, AP source says
Seth Rogen knows he can handle weed better than most
Hailey Van Lith vs. Louisville when TCU guard faces team she went deep in March Madness with 3 times
